Rejected at 6:34 p.m. Oct, 31, 2023 ] by Alex
Author: dheeraj
Related Note: 1481330704958
Rationale for change

Please remove the audio on this, it doesn't add much and startles people while studying since virtually no other cards have audio

Rejection reason

unresolved after months, can revisit if more people dislike

Extra Extra
Text
The t({{c3::9}};{{c3::22}}) translocation generates a(n) {{c1::BCR-ABL fusion::specific}} protein with increased {{c2::tyrosine kinase}} activity
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy Extra
Empty field
Picmonic
Empty field
Physeo
Empty field
OME

Additional Resources
Other:

One by one
Empty field
#AK_Step1_v12::#UWorld::COMLEX::25844 #AK_Step1_v12::#UWorld::Step::12278 #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::03_Leukemia #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::09_Oncogenes_and_Tumor_Suppressor_Genes !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-WBC #AK_Step1_v12::#AMBOSS::V-0Gwi #AK_Step1_v12::#Pixorize::02_Immunology::07_Leukemias_&_Lymphomas::04_Chronic_Myelogenous_Leukemia_(CML) #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::14_Myeloproliferative_Disorders #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::leukemia #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::29_Myeloproliferative_neoplasms::*Chronic_Myeloproliferative_Disorders::Chronic_Myelogenous_Leukemia #AK_Step1_v12::#AMBOSS::IQaYx4 #AK_Step1_v12::#UWorld::Step::8281 #AK_Step1_v12::#Pathoma::06_WBC::04_Myeloproliferative #AK_Step2_v12::#AMBOSS::xt0Ef3 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::32_Chromosomal_translocations::*22 #AK_Step2_v12::#AMBOSS::Et0823 #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::01_Myeloproliferative_Neoplasms_&_Myelodysplastic_Syndromes #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::04_Oncology::02_Chronic_Leukemias_SOAP #AK_Step1_v12::#B&B::11_Hematology::03_White_Blood_Cells::02_Chronic_Leukemia #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::09_Oncogenes_and_Tumor_Suppressor_Genes #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::02_Acute_Myeloid_Leukemia_(AML)_&_Chronic_Myeloid_Leukemia_(CML) #AK_Step1_v12::#FirstAid::04_Pathology::03_Neoplasia::08_Oncogenes::*Signal_Transducers::BCR-ABL #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::05_Leukemia #AK_Step1_v12::#UWorld::COMLEX::25363 #AK_Step2_v12::#AMBOSS::Dt01f3 #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::leukemia #AK_Step1_v12::#Physeo::11_Pathology::07_General_Pathology::09_Carcinogenesis #AK_Step1_v12::#USMLERx::43200.1 #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::03_White_Cells::04_Chronic_Leukemias #AK_Step2_v12::#AMBOSS::o-a0yM #AK_Step2_v12::#AMBOSS::tS0XYf #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::09_Leukemias_and_Lymphomas::02_Chronic_Myeloid_Leukemia #AK_Step2_v12::#UWorld::COMLEX::28704 #AK_Step1_v12::#OME::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::03_Leukemia #AK_Step2_v12::#UWorld::Step::2894